Induction therapy with bolus ATG increases cyclosporine sensitivity in renal transplant recipients

Transplant Proc. 2001 May;33(3):2251-3. doi: 10.1016/s0041-1345(01)01980-7.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antilymphocyte Serum / administration & dosage
  • Antilymphocyte Serum / therapeutic use*
  • Azathioprine / therapeutic use
  • Creatinine / blood
  • Cyclosporine / adverse effects
  • Cyclosporine / blood
  • Cyclosporine / therapeutic use*
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • Histocompatibility Testing
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / physiology
  • Living Donors
  • Male
  • Middle Aged
  • Time Factors

Substances

  • Antilymphocyte Serum
  • Immunosuppressive Agents
  • Cyclosporine
  • Creatinine
  • Azathioprine